Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

265 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome.
Wheat LJ, Connolly P, Smedema M, Brizendine E, Hafner R; AIDS Clinical Trials Group and the Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Wheat LJ, et al. Among authors: hafner r. Clin Infect Dis. 2001 Dec 1;33(11):1910-3. doi: 10.1086/323781. Epub 2001 Oct 23. Clin Infect Dis. 2001. PMID: 11692303
Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy.
Goldman M, Zackin R, Fichtenbaum CJ, Skiest DJ, Koletar SL, Hafner R, Wheat LJ, Nyangweso PM, Yiannoutsos CT, Schnizlein-Bick CT, Owens S, Aberg JA; AIDS Clinical Trials Group A5038 Study Group. Goldman M, et al. Among authors: hafner r. Clin Infect Dis. 2004 May 15;38(10):1485-9. doi: 10.1086/420749. Epub 2004 Apr 28. Clin Infect Dis. 2004. PMID: 15156489
A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
Goldman M, Cloud GA, Wade KD, Reboli AC, Fichtenbaum CJ, Hafner R, Sobel JD, Powderly WG, Patterson TF, Wheat LJ, Stein DK, Dismukes WE, Filler SG; AIDS Clinical Trials Group Study Team 323; Mycoses Study Group Study Team 40. Goldman M, et al. Among authors: hafner r. Clin Infect Dis. 2005 Nov 15;41(10):1473-80. doi: 10.1086/497373. Epub 2005 Oct 12. Clin Infect Dis. 2005. PMID: 16231260 Clinical Trial.
Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole.
Wheat LJ, Cloud G, Johnson PC, Connolly P, Goldman M, Le Monte A, Fuller DE, Davis TE, Hafner R; AIDS Clinical Trials Group; Mycoses Study Group of NIAID. Wheat LJ, et al. Among authors: hafner r. Antimicrob Agents Chemother. 2001 Aug;45(8):2354-7. doi: 10.1128/AAC.45.8.2354-2357.2001. Antimicrob Agents Chemother. 2001. PMID: 11451696 Free PMC article. Clinical Trial.
Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS.
Johnson PC, Wheat LJ, Cloud GA, Goldman M, Lancaster D, Bamberger DM, Powderly WG, Hafner R, Kauffman CA, Dismukes WE; U.S. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Johnson PC, et al. Among authors: hafner r. Ann Intern Med. 2002 Jul 16;137(2):105-9. doi: 10.7326/0003-4819-137-2-200207160-00008. Ann Intern Med. 2002. PMID: 12118965 Free article. Clinical Trial.
Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group.
Wheat J, MaWhinney S, Hafner R, McKinsey D, Chen D, Korzun A, Shakan KJ, Johnson P, Hamill R, Bamberger D, Pappas P, Stansell J, Koletar S, Squires K, Larsen RA, Cheung T, Hyslop N, Lai KK, Schneider D, Kauffman C, Saag M, Dismukes W, Powderly W. Wheat J, et al. Among authors: hafner r. Am J Med. 1997 Sep;103(3):223-32. doi: 10.1016/s0002-9343(97)00151-4. Am J Med. 1997. PMID: 9316555 Free article.
Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.
Wheat J, Hafner R, Wulfsohn M, Spencer P, Squires K, Powderly W, Wong B, Rinaldi M, Saag M, Hamill R, Murphy R, Connolly-Stringfield P, Briggs N, Owens S; National Institute of Allergy and Infectious Diseases Clinical Trials and Mycoses Study Group Collaborators. Wheat J, et al. Among authors: hafner r. Ann Intern Med. 1993 Apr 15;118(8):610-6. doi: 10.7326/0003-4819-118-8-199304150-00006. Ann Intern Med. 1993. PMID: 8383934 Clinical Trial.
A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
Saag MS, Cloud GA, Graybill JR, Sobel JD, Tuazon CU, Johnson PC, Fessel WJ, Moskovitz BL, Wiesinger B, Cosmatos D, Riser L, Thomas C, Hafner R, Dismukes WE. Saag MS, et al. Among authors: hafner r. Clin Infect Dis. 1999 Feb;28(2):291-6. doi: 10.1086/515110. Clin Infect Dis. 1999. PMID: 10064246 Clinical Trial.
265 results